ReviewClinical and translational medicine2018
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials.
Christopher J LaRocca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
90 papers cite itlatest 60 shown
this paperpooled itcites it